Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome.

[1]  M. Saito,et al.  Experimental Diabetes Upregulates the Expression of Uretereral Endothelin Receptors , 1997, Peptides.

[2]  S. Douglas,et al.  Signal transduction mechanisms mediating the vascular actions of endothelin. , 1997, Journal of vascular research.

[3]  M. Webb,et al.  Inhibitors of endothelin , 1997, Medicinal research reviews.

[4]  H. Hama,et al.  Molecular pharmacology and pathophysiological significance of endothelin. , 1996, Japanese journal of pharmacology.

[5]  M. Saito,et al.  Characterization of endothelin receptors in streptozotocin-induced diabetic rat vas deferens. , 1996, Biochemical pharmacology.

[6]  M. Saito,et al.  Effect of experimental diabetes on rat prostate endothelin receptors. , 1996, European journal of pharmacology.

[7]  Y. Oztürk,et al.  Effects of experimental diabetes and insulin on smooth muscle functions. , 1996, Pharmacological reviews.

[8]  R. Moriuchi,et al.  Two subtypes of endothelin receptors and endothelin peptides are expressed in differential cell types of the rat placenta: in vitro receptor autoradiographic and in situ hybridization studies. , 1996, Endocrinology.

[9]  M. Polokoff,et al.  Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.

[10]  R. M. Weiss,et al.  Reversibility of Diabetes- and Diuresis-Induced Alterations in Rat Bladder Dome Muscarinic Receptors , 1994, Diabetes.

[11]  J. Huidobro-Toro,et al.  Involvement of ETA receptors in the facilitation by endothelin‐1 of non‐adrenergic non‐cholinergic transmission in the rat urinary bladder , 1994, British journal of pharmacology.

[12]  M. Lerner,et al.  Cloning and characterization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. , 1993, The Journal of biological chemistry.

[13]  Y. Matsuzawa,et al.  Effect of endothelin 1 on ion transport in isolated rat colon. , 1993, Gastroenterology.

[14]  Y. Urade,et al.  ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation. , 1993, European journal of pharmacology.

[15]  E. Levin,et al.  Insulin Stimulates Production and Secretion of Endothelin From Bovine Endothelial Cells , 1993, Diabetes.

[16]  A. Traish,et al.  Endothelin in the urinary bladder. II. Characterization of endothelin receptor subtypes. , 1992, The Journal of urology.

[17]  A. Traish,et al.  Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regulation. , 1992, The Journal of urology.

[18]  F. Marumo,et al.  Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. , 1992, The Journal of clinical investigation.

[19]  K. Andersson,et al.  Endothelin-1-induced contractions of isolated pig detrusor and vesical arterial smooth muscle: calcium dependence and phosphoinositide hydrolysis. , 1992, General pharmacology.

[20]  F. Murad,et al.  Interactions of endothelins and EDRF in bovine native endothelial cells: selective effects of endothelin-3. , 1992, The American journal of physiology.

[21]  Y. Urade,et al.  A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. , 1992, Biochemical and biophysical research communications.

[22]  R. Weiss,et al.  Differential Regulation of Bladder β-Adrenergic and Muscarinic Cholinergic Receptors in Experimental Diabetes , 1991, Diabetes.

[23]  H. Lodish,et al.  Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Jones,et al.  Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. , 1991, Biochemical and biophysical research communications.

[25]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[26]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[27]  K. Andersson,et al.  Contractile effects of endothelin-1 and localization of endothelin binding sites in rabbit lower urinary tract smooth muscle. , 1990, Acta physiologica Scandinavica.

[28]  D. Thibeault,et al.  Tissue Specificity of Endothelin Binding Sites , 1990, Journal of Cardiovascular Pharmacology.

[29]  M. Kuhar,et al.  Methods in Neurotransmitter Receptor Analysis , 1990 .

[30]  Y. Hirata,et al.  Specific receptors for endothelin‐3 in cultured bovine endothelial cells and its cellular mechanism of action , 1990, FEBS letters.

[31]  W. Nayler,et al.  Streptozotocin‐induced diabetes reduces the density of [125I]‐endothelin‐binding sites in rat cardiac membranes , 1989, British journal of pharmacology.

[32]  C. Maggi,et al.  Potent contractile activity of endothelin on the human isolated urinary bladder , 1989, British journal of pharmacology.

[33]  M. Yanagisawa,et al.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[35]  J. Belis,et al.  Abnormalities of rat bladder contractility in streptozotocin-induced diabetes mellitus. , 1986, The Journal of pharmacology and experimental therapeutics.

[36]  G. Burnstock,et al.  The smooth muscle of rat bladder in the early stages of streptozotocin-induced diabetes. , 1984, British journal of urology.

[37]  M. Shani,et al.  The nucleotide sequence of the rat cytoplasmic β–actin gene , 1983 .

[38]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[39]  M. Ellenberg.  Development of urinary bladder dysfunction in diabetes mellitus. , 1980, Annals of internal medicine.

[40]  H. Rosenthal.  A graphic method for the determination and presentation of binding parameters in a complex system. , 1967, Analytical biochemistry.

[41]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[42]  E. A. Martelli,et al.  Elevated urinary excretion of endothelins in streptozotocin diabetic rats. , 1994, Life sciences.

[43]  T. Hayama,et al.  Endothelin antagonistic peptide derivatives with high selectivity for ETA receptors , 1993 .

[44]  T. Fukami,et al.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. , 1992, Life sciences.

[45]  Hy. Lin.  Cloning and function expression of human endothelin-1 receptor cDNA , 1991 .

[46]  I. Miyamori,et al.  Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats. , 1991, Life sciences.

[47]  R. Weiss,et al.  Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors. , 1989, The Journal of pharmacology and experimental therapeutics.